Pharmaceuticals

Drug Development Biotechnology Acquisitions Drug Pricing Manufacturing Drug Manufacturing Vaccine Development Pharmaceutical Companies Market Trends Market Competition

GSK Beats Q2 Estimates and Launches £1.9 Billion Efficiency Programme

The company says the savings will free capital to speed late-stage drug development as it keeps 2026 guidance and expands UK R&D.

AHA Says Up to Five Cups of Coffee a Day Is Safe for Most Adults

Novo Nordisk Asks Court to Halt Lilly’s National GLP‑1 Ads

FDA Approves Lytenava, First Ophthalmic Bevacizumab for Wet AMD

argenx Posts $1.52 Billion Quarter as VYVGART Readouts Loom

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading Weight-Loss and Diabetes Ads

Lilly to Acquire AtaiBeckley in Deal Valued Up to $3.8 Billion

Thyme Care Founder Robin Shah Moves to Executive Chairman as Brad Diephuis Is Named CEO

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

Oxford Launches First Human Trial of Bundibugyo Ebola Vaccine

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

Catnip Lotion Matches DEET in Ugandan Mosquito Trials

Vertex to Buy Crinetics for $10 Billion, Gaining Oral Endocrine Drugs

Novartis to Acquire Myricx Bio for Up to $1.5 Billion

Viking Therapeutics Rallies as Weight‑Loss Program Moves Toward Late‑Stage Testing

Missouri Jury Clears Mead Johnson in Preterm Formula NEC Lawsuit

Takeda Signs $600 Million‑Value AI Drug Discovery Deal With Insilico

FDA Allows Zyn to Be Marketed as Lower Risk Than Cigarettes

House Select Committee Opens National-Security Inquiries Into Merck and AbbVie China Trials

Medicare Launches 18‑Month GLP‑1 Bridge to Cover Weight‑Loss Drugs